- Home
- AVNW vs DMAC Comparison
AVNW vs DMAC Comparison
Compare AVNW & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNW
- DMAC
- Stock Information
- Founded
- AVNW 2006
- DMAC 2000
- Country
- AVNW United States
- DMAC United States
- Employees
- AVNW N/A
- DMAC N/A
- Industry
- AVNW Radio And Television Broadcasting And Communications Equipment
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- AVNW Technology
- DMAC Health Care
- Exchange
- AVNW Nasdaq
- DMAC Nasdaq
- Market Cap
- AVNW 241.8M
- DMAC 267.7M
- IPO Year
- AVNW 2007
- DMAC N/A
- Fundamental
- Price
- AVNW $22.57
- DMAC $6.51
- Analyst Decision
- AVNW Strong Buy
- DMAC Strong Buy
- Analyst Count
- AVNW 5
- DMAC 3
- Target Price
- AVNW $37.60
- DMAC $7.00
- AVG Volume (30 Days)
- AVNW 271.9K
- DMAC 81.8K
- Earning Date
- AVNW 02-04-2025
- DMAC 03-18-2025
- Dividend Yield
- AVNW N/A
- DMAC N/A
- EPS Growth
- AVNW N/A
- DMAC N/A
- EPS
- AVNW N/A
- DMAC N/A
- Revenue
- AVNW $434,108,000.00
- DMAC N/A
- Revenue This Year
- AVNW $8.97
- DMAC N/A
- Revenue Next Year
- AVNW $7.64
- DMAC N/A
- P/E Ratio
- AVNW N/A
- DMAC N/A
- Revenue Growth
- AVNW 22.94
- DMAC N/A
- 52 Week Low
- AVNW $12.96
- DMAC $2.14
- 52 Week High
- AVNW $38.85
- DMAC $6.82
- Technical
- Relative Strength Index (RSI)
- AVNW 57.64
- DMAC 62.22
- Support Level
- AVNW $21.74
- DMAC $5.75
- Resistance Level
- AVNW $23.37
- DMAC $6.82
- Average True Range (ATR)
- AVNW 1.38
- DMAC 0.30
- MACD
- AVNW -0.07
- DMAC 0.02
- Stochastic Oscillator
- AVNW 51.26
- DMAC 74.48
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.